Skip to main content
. 2009 Jun 8;8:127. doi: 10.1186/1475-2875-8-127

Figure 5.

Figure 5

Cost-effectiveness of vaccines given different levels of mass vaccination coverage by transmission setting*. Results obtained assuming a vaccine half-life of 10 years and homogeneity value of 10, and vaccine price of US$2. *data for EIR in some cases are not shown in the figure due to a scale problem.